The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ADVANTAGE SOLUTIONS INC COM CL A 00791N102   1,294,742 980,865 SH   SOLE   980,865 0 0
ATLANTA BRAVES HLDGS INC COM SER C 047726302   4,387,540 93,811 SH   SOLE   93,811 0 0
BANDWIDTH INC NOTE 0.500% 4/0 05988JAD5   33,773,775 40,250,000 PRN   SOLE   40,250,000 0 0
BLACKBAUD INC COM 09227Q100   12,392,530 193,000 SH   SOLE   193,000 0 0
EMBECTA CORP COMMON STOCK 29082K105   2,150,579 221,938 SH   SOLE   221,938 0 0
ESPERION THERAPEUTICS INC NE COM 29664W105   2,953,200 3,000,000 SH   SOLE   3,000,000 0 0
IRONWOOD PHARMACEUTICALS INC NOTE 1.500% 6/1 46333XAH1   14,419,400 17,000,000 PRN   SOLE   17,000,000 0 0
ON24 INC COM 68339B104   23,024,590 4,240,256 SH   SOLE   4,240,256 0 0
SUMMIT HOTEL PPTYS NOTE 1.500% 2/1 866082AA8   28,141,695 29,039,000 PRN   SOLE   29,039,000 0 0
TRAVERE THERAPEUTICS INC NOTE 2.500% 9/1 761299AB2   12,849,200 13,000,000 PRN   SOLE   13,000,000 0 0